Yoshida H, Inoda S, Takahashi H, Takahashi R, et al. Two-year outcomes of intravitreal brolucizumab for neovascular age-related macular degeneration: treat, extend, and stop-protocol. Graefes Arch Clin Exp Ophthalmol 2024 Jul 12. doi: 10.1007/s00417-024-06577.
PMID: 38995352